Condition: Biliary Dyspepsia · Sponsor: Myungmoon Pharma. Co. Ltd.
The objective of this clinical trial is to evaluate the efficacy and safety of CnU capsule 500 mg administration in patients with biliary dyspepsia
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Pusan National University Hospital | Busan, South Korea | Recruiting |
| CHA Bundang Medical Center | Gyeonggi-do, South Korea | Recruiting |
| Hallym University Dongtan Sacred Heart Hospital | Gyeonggi-do, South Korea | Recruiting |
| Soonchunhyang University Cheonan Hospital | Gyeonggi-do, South Korea | Recruiting |
| Inha University Hospital | Incheon, South Korea | Recruiting |
| Gangnam Severance Hospital | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07016269